Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 232-092-5
CAS number: 7786-17-6
ANALYSIS OF DOSE PREPARATIONS
Samples of Day 6
> Accuracy of preparation:
- No test material was detected in the
- The concentrations analysed in the
100, 300 and 1000 mg/kg bw/day formulations were not in agreement with
target concentrations since the mean accuracies were outside the
acceptability range of 85-115%; with mean accuracies of 84%, 117% and
The 100 and 1000 mg/kg bw/day
formulations were not homogeneous since the coefficients of variation
were 17% and 42%, respectively.
Analysis of Group 2 and Group 4
formulations after storage yielded a relative difference of 27% and
-24%. The relatively large differences are probably caused by an
inhomogeneity in the formulations rather than degradation of the test
Samples of Day 10
- The concentrations analysed in the
100, 300 and 1000 mg/kg bw/day formulations were in agreement with
target concentrations, mean accuracies were between 85% and 115%.
The homogeneity of the 100 and 1000
mg/kg bw/day formulations was still above the criterion of 10%. However,
the resulting coefficients of variation were 14% and 11% respectively,
were still considered acceptable.
Analysis of 100 and 1000 mg/kg be/day
formulations after storage yielded a relative difference of 12% and
-9.4%. The formulations are found to be stable when the relative
difference is ≤ 10%. Since the relative difference of the 100 mg/kg
bw/day formulations of 12% was an increase in concentration, no
degradation occurred. The relatively large differences are probably
caused by an inhomogeneity in the formulations. The analytical method
showed a higher variability at the low concentration level (i.e. a
coefficient of variation of 11 and 18% of the procedural recovery
samples) which possibly results in a higher variability of the
analytical formulation results as well. The formulations are thus
considered to be stable during storage at room temperature under normal
laboratory light conditions for at least 6 hours.
Table 1: Developmental Data
Dose Level mg/kg bw/day
Mean duration of gestation
Mean number of dead pups at first litter check
Living Pups at first litter check
% of males/females
% of living pups
Table 2: Pup Bodyweight
Mean ± SD
6.6 ± 0.5
6.4 ± 0.6
6.5 ± 0.8
6.3 ± 0.4
6.1 ± 0.6
6.2 ± 0.6
6.5 ± 0.5
6.4 ± 0.4
9.9 ± 0.9
9.6 ± 1.1
9.8 ± 1.3
10.3 ± 1.0
9.5 ± 0.8
9.3 ± 1.3
9.4 ± 1.1
9.7 ± 0.7
9.8 ± 0.9
9.4 ± 1.2
10.1 ± 1.0
Table 3: Corpora Lutea and Implantation Sites Summary
Developmental toxicity was determined in a reproduction/development
toxicity screening test, performed under GLP conditions and in line with
the standardised guidelines OECD 421 and EPA OPPTS 870.3550. Based on
the results of a 10-day dose range finding study, Crl:WI(Han) rats were
dosed at 100, 300 and 1000 mg/kg bw/day, formulated in propylene glycol,
and administered via oral gavage.
Ten males per dose were exposed for 29 days (2 weeks prior to mating,
during mating, and up to termination), and ten females per dose were
exposed for 39-54 days (during 2 weeks prior to mating, during mating,
during post-coitum, and during at least 4 days of lactation).
The accuracy, homogeneity and stability
results were outside the acceptable range during the first formulation
analysis. Subsequent analyses revealed the formulations were prepared
accurately and were considered stable for at least 6 hours at room
temperature, though formulations were not homogeneous. The results were
attributable to an interaction between limited sensitivity of the
analytical method and the nature of the test material itself and were
ultimately accepted. The inhomogeneity of the test material had no
negative impact on the study as formulations were stirred constantly
No signs of maternal toxicity were noted during exposure or at necropsy
up to the maximum dose level tested. Thus the NOAEL for maternal
toxicity was considered to be 1000 mg/kg bw/day.
No toxicologically relevant effects on gestation index and duration,
parturition, maternal care and early postnatal pup development
(mortality, clinical signs, body weight and macroscopy) were observed up
to the maximum dose level. Based on these findings the NOAEL for
developmental toxicity was determined to be 1000 mg/kg bw/day.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Deze website maakt gebruik van cookies om het surfen zo aangenaam mogelijk te maken.
Welcome to the ECHA website. This site is not fully supported in Internet Explorer 7 (and earlier versions). Please upgrade your Internet Explorer to a newer version.
Do not show this message again